Lataa...
Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?
Controversy exists regarding the optimal use of the 23-valent pneumococcal conjugate vaccine for the protection of high-risk individuals, such as children and adults with immunocompromising conditions and the elderly. The effectiveness and immunogenicity of 23-valent pneumococcal polysaccharide vacc...
Tallennettuna:
| Julkaisussa: | Clin Vaccine Immunol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4860474/ https://ncbi.nlm.nih.gov/pubmed/27009210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00721-15 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|